Log in to save to my catalogue

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability...

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2532583012

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults

About this item

Full title

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults

Publisher

Durham: Research Square

Journal title

Trials, 2019

Language

English

Publication information

Publisher

Durham: Research Square

More information

Scope and Contents

Contents

Background Irritable Bowel Syndrome (IBS) with diarrhoea (IBS-D) is a common and chronic condition that can significantly impair quality of life. The emergence of new drugs for IBS-D has been slow and there is a need for new treatments, including drug-free treatments, which are easy to use and suitable for different patient groups. Currently availa...

Alternative Titles

Full title

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2532583012

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2532583012

Other Identifiers

DOI

10.21203/rs.2.12205/v2